A Law360 article highlights Ropes & Gray advising CAMP4 Therapeutics in its $75 million initial public offering on the Nasdaq Global Market under the trading symbol “CAMP” which priced on Oct. 10. Camp4 is raising proceeds to develop RNA-based therapies to treat genetic diseases, including those affecting metabolism and the central nervous system.
The article cites the Ropes & Gray CAMP4 IPO deal team that included capital markets partner Tom Danielski, life sciences partner Marc Rubenstein and capital markets associate Lisa Folkerth, employment & benefits partner Renata Ferrari, life sciences regulatory & compliance partner Kellie Combs and health care counsel Alison Fethke.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.